Strumento inattivo

Altre lingue CytRx Corporation Nasdaq

Azioni

US2328286081

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

LadRx: Q1 Earnings Snapshot	15/05
LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
FDA Acceptance of Zevra's Arimoclomol NDA Filing for Niemann-Pick Disease Type C Results in XOMA Making a $1 Million Milestone Payment to LadRx	12/01
Xoma to Make $1 Million Milestone Payment to LadRx After FDA Accepts Zevra Application for Arimoclomol	11/01
LadRx Issues 2024 Update to Shareholders	09/01
LadRx: Q3 Earnings Snapshot	14/11
LadRx Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
LadRx : Modification to Rights of Security Holders - Form 8-K	11/09/23
LadRx: Q2 Earnings Snapshot	14/08/23
LadRx Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Investor Presentation: July 2023	15/07/23
LadRx Completes Non-Dilutive Financing Transaction for up to $11 Million with XOMA Corporation	22/06/23
LadRx Announces Reverse Stock Split Effective as of May 17, 2023	18/05/23
LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
LadRx Announces Reverse Stock Split	10/05/23
LadRx Corporation has filed an IPO in the amount of $24 million.	14/04/23
LadRx Highlights Patent Issued for Its LADR Technology	27/03/23
LadRx Highlights Patent Issued for Its LADR Technology	27/03/23
LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	20/03/23
LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	20/03/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue CytRx Corporation Nasdaq

Azioni

US2328286081

Altre lingue

Filtri